Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/MenAfriVac> ?p ?o }
Showing triples 1 to 62 of
62
with 100 triples per page.
- MenAfriVac abstract "MenAfriVac is a vaccine developed for use in sub-Saharan Africa that protects infants under one year old to people up to 29 years of age against meningococcal bacterium Neisseria meningitidis group A. MenAfriVac costs under US$0.50 per dose and reduces carriage of the bacteria from one person to another. The Meningitis Vaccine Project, a partnership between the Program for Appropriate Technology in Health (PATH) and the World Health Organization, worked with a consortium of international partners to develop the vaccine.".
- MenAfriVac wikiPageExternalLink product_menafrivac.htm.
- MenAfriVac wikiPageID "29735583".
- MenAfriVac wikiPageLength "7290".
- MenAfriVac wikiPageOutDegree "36".
- MenAfriVac wikiPageRevisionID "656338980".
- MenAfriVac wikiPageWikiLink Affinity_chromatography.
- MenAfriVac wikiPageWikiLink African_meningitis_belt.
- MenAfriVac wikiPageWikiLink Ammonium_sulfate_precipitation.
- MenAfriVac wikiPageWikiLink Benin.
- MenAfriVac wikiPageWikiLink Bill_&_Melinda_Gates_Foundation.
- MenAfriVac wikiPageWikiLink Burkina_Faso.
- MenAfriVac wikiPageWikiLink Cameroon.
- MenAfriVac wikiPageWikiLink Carrier_protein.
- MenAfriVac wikiPageWikiLink Category:Meningitis.
- MenAfriVac wikiPageWikiLink Category:Meningococcal_vaccines.
- MenAfriVac wikiPageWikiLink Category:Public_health.
- MenAfriVac wikiPageWikiLink Center_for_Biologics_Evaluation_and_Research.
- MenAfriVac wikiPageWikiLink Central_African_Republic.
- MenAfriVac wikiPageWikiLink Chad.
- MenAfriVac wikiPageWikiLink Clostridium_tetani.
- MenAfriVac wikiPageWikiLink Côte_d’Ivoire.
- MenAfriVac wikiPageWikiLink Ethiopia.
- MenAfriVac wikiPageWikiLink Formaldehyde.
- MenAfriVac wikiPageWikiLink Freeze-drying.
- MenAfriVac wikiPageWikiLink Ghana.
- MenAfriVac wikiPageWikiLink Ivory_Coast.
- MenAfriVac wikiPageWikiLink Mali.
- MenAfriVac wikiPageWikiLink Meningitis_Vaccine_Project.
- MenAfriVac wikiPageWikiLink Mueller-Hinton_agar.
- MenAfriVac wikiPageWikiLink Neisseria_meningitidis.
- MenAfriVac wikiPageWikiLink Niger.
- MenAfriVac wikiPageWikiLink Nigeria.
- MenAfriVac wikiPageWikiLink PATH_(global_health_organization).
- MenAfriVac wikiPageWikiLink Polysaccharide.
- MenAfriVac wikiPageWikiLink Program_for_Appropriate_Technology_in_Health.
- MenAfriVac wikiPageWikiLink Serum_Institute_of_India.
- MenAfriVac wikiPageWikiLink SynCo_Bio_Partners.
- MenAfriVac wikiPageWikiLink Tetanospasmin.
- MenAfriVac wikiPageWikiLink The_Lancet.
- MenAfriVac wikiPageWikiLink Togo.
- MenAfriVac wikiPageWikiLink World_Health_Organization.
- MenAfriVac wikiPageWikiLinkText "MenAfriVac".
- MenAfriVac hasPhotoCollection MenAfriVac.
- MenAfriVac wikiPageUsesTemplate Template:PATH.
- MenAfriVac wikiPageUsesTemplate Template:Reflist.
- MenAfriVac subject Category:Meningitis.
- MenAfriVac subject Category:Meningococcal_vaccines.
- MenAfriVac subject Category:Public_health.
- MenAfriVac hypernym Vaccine.
- MenAfriVac type Drug.
- MenAfriVac type Disorder.
- MenAfriVac type Drug.
- MenAfriVac type Science.
- MenAfriVac comment "MenAfriVac is a vaccine developed for use in sub-Saharan Africa that protects infants under one year old to people up to 29 years of age against meningococcal bacterium Neisseria meningitidis group A. MenAfriVac costs under US$0.50 per dose and reduces carriage of the bacteria from one person to another.".
- MenAfriVac label "MenAfriVac".
- MenAfriVac sameAs MenAfriVac.
- MenAfriVac sameAs m.0fq0b92.
- MenAfriVac sameAs Q6816185.
- MenAfriVac sameAs Q6816185.
- MenAfriVac wasDerivedFrom MenAfriVac?oldid=656338980.
- MenAfriVac isPrimaryTopicOf MenAfriVac.